Vitamin D receptor polymorphisms in colorectal cancer in New Zealand: An association study

New Zealand Medical Journal

Volumn 125, Issue 1356, 2012, Pages 47-51

  Bentley, Robert W ^a   Keown, Dayle A ^a   Gearry, Richard B ^a   Cameron, Vicky A ^a   Keenan, Jacqui ^a   Roberts, Rebecca L ^a,b   Day, Andrew S ^b,c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D RECEPTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; NEW ZEALAND; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RECEPTORS, CALCITRIOL;

EID: 84862229926     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Thotathil ZS, Long JE, Kennedy I, et al. Chemotherapy prescription patterns in colon cancer: a patterns-of-care survey in New Zealand. N Z Med J. 2007;120:U2636.
2. Jenab M, Bueno-de-Mesquita HB, Ferrari P, et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ. 2010;340:b5500.
3. Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. Faseb J. 2001;15:2579-2585.
4. Rheem DS, Baylink DJ, Olafsson S, et al. Prevention of colorectal cancer with vitamin D. Scand J Gastroenterol. 2010;45:775-784.
5. Aune D, Lau R, Chan DS, et al. Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studies. Ann Oncol. 2011;23:37-45.
6. Baker AR, McDonnell DP, Hughes M, et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci U S A. 1988;85:3294-3298.
7. Liu PT, Modlin RL. Human macrophage host defense against Mycobacterium tuberculosis. Curr Opin Immunol. 2008;20:371-376.
8. White JH. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun. 2008;76:3837-3843.
9. Wang TT, Dabbas B, Laperriere D, et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem. 2010;285:2227-2231.
10. Mathew S, Murty VV, Hunziker W, et al. Subregional mapping of 13 single-copy genes on the long arm of chromosome 12 by fluorescence in situ hybridization. Genomics. 1992;14:775-779.
11. Mahmoudi T, Mohebbi SR, Pourhoseingholi MA, et al. Vitamin D receptor gene ApaI polymorphism is associated with susceptibility to colorectal cancer. Dig Dis Sci. 2010;55:2008-2013.
12. Flugge J, Krusekopf S, Goldammer M, et al. Vitamin D receptor haplotypes protect against development of colorectal cancer. Eur J Clin Pharmacol. 2007;63:997-1005.
13. Slattery ML, Herrick J, Wolff RK, et al. CDX2 VDR polymorphism and colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:2752-2755.
14. Touvier M, Chan DS, Lau R, et al. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2011;20:1003-1016.
15. Ellis KL FC, Doughty RN, et al. Genomic Risk Variants at 1p13.3, 1q41 and 3q22.3 are Associated with Subsequent Cardiovascular Outcomes in Healthy Controls and in Established Coronary Artery Disease Circulation. Cardiovascular Genetics. 2011.
16. Garnero P, Borel O, Sornay-Rendu E, et al. Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: the OFELY Study. J Bone Miner Res. 1996;11:827-834.
17. Hutchinson PE, Osborne JE, Lear JT, et al. Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res. 2000;6:498-504.
18. Ingles SA, Wang J, Coetzee GA, et al. Vitamin D receptor polymorphisms and risk of colorectal adenomas (United States). Cancer Causes Control. 2001;12:607-614.
19. Kim HS, Newcomb PA, Ulrich CM, et al. Vitamin D receptor polymorphism and the risk of colorectal adenomas: evidence of interaction with dietary vitamin D and calcium. Cancer Epidemiol Biomarkers Prev. 2001;10:869-874.
20. Slattery ML, Neuhausen SL, Hoffman M, et al. Dietary calcium, vitamin D, VDR genotypes and colorectal cancer. Int J Cancer. 2004;111:750-756.
21. Ochs-Balcom HM, Cicek MS, Thompson CL, et al. Association of vitamin D receptor gene variants, adiposity and colon cancer. Carcinogenesis. 2008;29:1788-1793.